Fingerprint
Dive into the research topics of 'The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma
V. Munugalavadla, S. Mariathasan, D. Slaga, C. Du, L. Berry, G. Del Rosario, Y. Yan, M. Boe, L. Sun, L. S. Friedman, M. Chesi, P. Leif Bergsagel, A. Ebens
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations